Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $11.35, for a total value of $340,500.00. Following the sale, the insider now directly owns 1,696,097 shares in the company, valued at $19,250,700.95. This trade represents a 1.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, October 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.77, for a total transaction of $323,100.00.
• On Thursday, August 22nd, Dawn Christine Maroney sold 7,074 shares of Alignment Healthcare stock. The stock was sold at an average price of $9.02, for a total transaction of $63,807.48.

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock opened at $11.49 on Friday. The stock has a market cap of $2.20 billion, a price-to-earnings ratio of -14.92 and a beta of 1.45. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The stock has a 50 day moving average price of $11.59 and a 200-day moving average price of $9.38. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $14.25.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14). Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company had revenue of $692.43 million during the quarter, compared to analyst estimates of $662.11 million. During the same period in the previous year, the firm earned ($0.19) earnings per share. Alignment Healthcare’s quarterly revenue was up 51.6% compared to the same quarter last year. Equities analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have issued reports on ALHC. Barclays lifted their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 30th. Piper Sandler reaffirmed an “overweight” rating and issued a $10.00 target price (up from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. UBS Group increased their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Robert W. Baird lifted their price objective on Alignment Healthcare from $10.00 to $11.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 14th. Finally, Stifel Nicolaus increased their target price on Alignment Healthcare from $9.00 to $12.00 and gave the company a “buy” rating in a research report on Friday, July 26th. One analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and an average price target of $10.33.

Hedge Funds Weigh In On Alignment Healthcare

Several hedge funds have recently added to or reduced their stakes in ALHC. Jacobs Levy Equity Management Inc. purchased a new position in shares of Alignment Healthcare during the first quarter valued at approximately $918,000. Vanguard Group Inc. boosted its holdings in Alignment Healthcare by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company’s stock valued at $45,828,000 after acquiring an additional 93,262 shares during the period. Deerfield Management Company L.P. Series C increased its stake in Alignment Healthcare by 31.8% in the second quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after purchasing an additional 2,630,788 shares during the period. Bank of New York Mellon Corp lifted its position in shares of Alignment Healthcare by 27.5% during the second quarter. Bank of New York Mellon Corp now owns 382,462 shares of the company’s stock worth $2,991,000 after purchasing an additional 82,559 shares during the last quarter. Finally, Hood River Capital Management LLC boosted its stake in shares of Alignment Healthcare by 6.4% during the second quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company’s stock valued at $24,294,000 after purchasing an additional 185,854 shares during the period. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.